Table 1. Baseline characteristics of the study group.
| Type of MI | n | % |
| Antero-lateral STEMI | 17 | 36 |
| Infero-posterior STEMI | 17 | 36 |
| New LBBB | 2 | 4 |
| NSTEMI | 11 | 23 |
| Right ventricle infarction | 10 | 21 |
| Cardiovascular risk factors | n | % |
| Hypertension | 27 | 58 |
| Diabetes mellitus | 12 | 26 |
| Active smokers | 16 | 34 |
| History of MI | 15 | 32 |
| Parameter (units) on admission | Median | (Q1; Q3) |
| Creatinine (umol/l) | 111 | (94; 136) |
| GFR (ml/min/1,73m2) | 49 | (37; 63) |
| ALAT (U/l) | 41,5 | (23; 156) |
| ASPAT(U/l) | 111 | (40; 184) |
| CRP hs (mg/l) | 7,7 | (2.5; 22.6) |
| Electrical instability | n | % |
| VF/VT acute | 21 | 45 |
| AVB | 11 | 23 |
| Other | Median | (Q1; Q3) |
| SBP (mmHg) | 90 | (70; 100) |
| HR (beat/min) | 94 | (80; 110) |
| SI | 1,1 | (0.9; 1.4) |
| TRI | 48 | (31; 79) |
| B-blocker before admission (n; %) | 18 | 38 |
MI, myocardial infarct; STEMI, ST-segment elevation myocardial infarction; LBBB, left bundle branch block; NSTEMI, non-ST-elevation myocardial infarction, GFR, glomerular filtration rate; VF, ventricular fibrillation; VT, ventricular tachycardia; AVB, atrioventricular block; SBP systolic blood pressure; HR, heart rate; SI, Shock Index; TRI, TIMI Risk Index.